U.S. market Open. Closes in 4 hours 53 minutes

KRRO | Korro Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/AN/A14.07M36.98M28.95MN/AN/A
Cost of Revenue3.63M2.51M3.84M1.58M16.81M654.00K531.00K
Gross Profit-3.63M-2.51M10.23M35.40M12.13M-654.00K-531.00K
Operating Expenses84.53M59.00M35.49M62.95M32.81M18.29M15.78M
Selling, General & Admin27.28M16.80M11.69M26.30M14.47M6.71M3.99M
Research & Development57.25M42.20M23.80M36.66M18.33M11.58M11.79M
Other Operating ExpensesN/A976.00K13.54MN/AN/AN/AN/A
Operating Income-84.53M-59.00M-35.49M-27.55M-20.68M-18.94M-16.31M
Other Expenses / Income3.39M976.00K13.54M1.07M1.93M-224.00K-3.93M
Before Tax Income-81.14M-58.02M-21.96M-26.48M-18.75M-19.17M-20.24M
Income Tax Expenses27.00K10.00K2.00K35.00KN/AN/A1.00
Net Income-81.17M-58.03M-21.96M-26.51M-18.75M-19.17M-20.24M
Interest ExpensesN/A118.00KN/AN/AN/A106.00K174.00K
Basic Shares Outstanding1.53M255.00K4.45M645.06K616.89K627.09K627.09K
Diluted Shares Outstanding1.53M255.17K4.45M645.06K616.89K627.09K627.09K
EBITDA-80.90M-56.49M-33.90M-24.90M-17.93M-18.41M-19.53M
EBITDA Margin0.00%0.00%-240.97%-67.32%-61.95%0.00%0.00%
EBIT-81.14M-57.90M-21.96M-26.48M-18.75M-19.06M-20.06M
EBIT Margin0.00%0.00%-156.08%-71.59%-64.76%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙